Correlation Between Singapore Reinsurance and Microbot Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Singapore Reinsurance and Microbot Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Singapore Reinsurance and Microbot Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Singapore Reinsurance and Microbot Medical, you can compare the effects of market volatilities on Singapore Reinsurance and Microbot Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Singapore Reinsurance with a short position of Microbot Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Singapore Reinsurance and Microbot Medical.

Diversification Opportunities for Singapore Reinsurance and Microbot Medical

0.58
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Singapore and Microbot is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Singapore Reinsurance and Microbot Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Microbot Medical and Singapore Reinsurance is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Singapore Reinsurance are associated (or correlated) with Microbot Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Microbot Medical has no effect on the direction of Singapore Reinsurance i.e., Singapore Reinsurance and Microbot Medical go up and down completely randomly.

Pair Corralation between Singapore Reinsurance and Microbot Medical

Assuming the 90 days trading horizon Singapore Reinsurance is expected to generate 1.0 times more return on investment than Microbot Medical. However, Singapore Reinsurance is 1.0 times more volatile than Microbot Medical. It trades about 0.18 of its potential returns per unit of risk. Microbot Medical is currently generating about 0.1 per unit of risk. If you would invest  3,140  in Singapore Reinsurance on September 1, 2024 and sell it today you would earn a total of  340.00  from holding Singapore Reinsurance or generate 10.83% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Singapore Reinsurance  vs.  Microbot Medical

 Performance 
       Timeline  
Singapore Reinsurance 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Singapore Reinsurance are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Singapore Reinsurance may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Microbot Medical 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Microbot Medical are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Microbot Medical unveiled solid returns over the last few months and may actually be approaching a breakup point.

Singapore Reinsurance and Microbot Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Singapore Reinsurance and Microbot Medical

The main advantage of trading using opposite Singapore Reinsurance and Microbot Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Singapore Reinsurance position performs unexpectedly, Microbot Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Microbot Medical will offset losses from the drop in Microbot Medical's long position.
The idea behind Singapore Reinsurance and Microbot Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital